Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystinosis | 6 | 2022 | 16 | 1.560 |
Why?
|
| Kidney Transplantation | 3 | 2020 | 755 | 1.350 |
Why?
|
| Fever of Unknown Origin | 2 | 2018 | 63 | 1.310 |
Why?
|
| Exostoses, Multiple Hereditary | 2 | 2019 | 26 | 0.780 |
Why?
|
| Exostoses | 1 | 2019 | 4 | 0.700 |
Why?
|
| Graft Rejection | 2 | 2018 | 834 | 0.600 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 417 | 0.560 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 184 | 0.560 |
Why?
|
| Kidney Failure, Chronic | 3 | 2018 | 960 | 0.560 |
Why?
|
| Cysteamine | 4 | 2022 | 15 | 0.550 |
Why?
|
| Developmental Disabilities | 2 | 2019 | 674 | 0.540 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 1375 | 0.530 |
Why?
|
| Hypertension | 2 | 2019 | 1503 | 0.480 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2009 | 16 | 0.360 |
Why?
|
| Mycophenolic Acid | 2 | 2018 | 148 | 0.320 |
Why?
|
| Fanconi Syndrome | 3 | 2022 | 10 | 0.290 |
Why?
|
| Myelolipoma | 1 | 2005 | 12 | 0.280 |
Why?
|
| Adrenocortical Adenoma | 1 | 2005 | 22 | 0.270 |
Why?
|
| Renal Insufficiency | 2 | 2020 | 321 | 0.270 |
Why?
|
| Hemorrhage | 1 | 2009 | 712 | 0.260 |
Why?
|
| Renal Dialysis | 3 | 2018 | 945 | 0.250 |
Why?
|
| Adrenalectomy | 1 | 2005 | 188 | 0.250 |
Why?
|
| Biopsy | 3 | 2018 | 3443 | 0.240 |
Why?
|
| Lung Diseases | 1 | 2009 | 717 | 0.240 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 551 | 0.210 |
Why?
|
| Acute Kidney Injury | 1 | 2009 | 739 | 0.210 |
Why?
|
| Nephrologists | 1 | 2021 | 13 | 0.200 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2005 | 489 | 0.200 |
Why?
|
| Adolescent | 10 | 2019 | 31252 | 0.190 |
Why?
|
| Bone Marrow | 2 | 2018 | 2358 | 0.190 |
Why?
|
| Pediatricians | 1 | 2021 | 58 | 0.190 |
Why?
|
| Gallbladder | 1 | 2020 | 69 | 0.190 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2020 | 9 | 0.180 |
Why?
|
| Histoplasma | 1 | 2018 | 32 | 0.170 |
Why?
|
| Antigens, Fungal | 1 | 2018 | 40 | 0.170 |
Why?
|
| Renin | 1 | 2019 | 92 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2019 | 402 | 0.170 |
Why?
|
| Histoplasmosis | 1 | 2018 | 74 | 0.160 |
Why?
|
| Bone Diseases | 1 | 2019 | 143 | 0.160 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 125 | 0.160 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2017 | 21 | 0.150 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 18 | 0.150 |
Why?
|
| Amphotericin B | 1 | 2018 | 289 | 0.150 |
Why?
|
| Leukocyte Count | 1 | 2018 | 684 | 0.150 |
Why?
|
| Kidney | 2 | 2020 | 2146 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2005 | 1225 | 0.140 |
Why?
|
| Viral Load | 1 | 2018 | 493 | 0.140 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 1005 | 0.140 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 81 | 0.140 |
Why?
|
| Heterozygote | 1 | 2019 | 1020 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 2019 | 875 | 0.130 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 482 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 158 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 462 | 0.130 |
Why?
|
| Cystine Depleting Agents | 1 | 2014 | 2 | 0.130 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 174 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2018 | 492 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 384 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 1998 | 589 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 2170 | 0.100 |
Why?
|
| Cerebral Ventricles | 1 | 2012 | 98 | 0.100 |
Why?
|
| Humans | 18 | 2022 | 261506 | 0.100 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2012 | 49 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2018 | 1230 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 516 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2020 | 32848 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2012 | 183 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1516 | 0.090 |
Why?
|
| Female | 11 | 2020 | 141928 | 0.090 |
Why?
|
| Phenotype | 2 | 2019 | 6295 | 0.090 |
Why?
|
| Methylprednisolone | 1 | 2009 | 193 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 208 | 0.080 |
Why?
|
| Craniofacial Abnormalities | 1 | 2010 | 239 | 0.080 |
Why?
|
| Child | 9 | 2021 | 29154 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 461 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2992 | 0.070 |
Why?
|
| Infant | 5 | 2020 | 13310 | 0.060 |
Why?
|
| Hemofiltration | 1 | 2004 | 20 | 0.060 |
Why?
|
| Carbamazepine | 1 | 2004 | 49 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 998 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2020 | 16273 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 5539 | 0.060 |
Why?
|
| Neonatal Screening | 1 | 2022 | 165 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2004 | 431 | 0.050 |
Why?
|
| Male | 8 | 2020 | 123000 | 0.050 |
Why?
|
| Quality of Life | 1 | 2014 | 4532 | 0.050 |
Why?
|
| Nephrology | 1 | 2021 | 151 | 0.040 |
Why?
|
| Lung | 1 | 2009 | 3151 | 0.040 |
Why?
|
| Iohexol | 1 | 2017 | 58 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 7551 | 0.040 |
Why?
|
| Triiodobenzoic Acids | 1 | 2017 | 68 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 390 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 43 | 0.040 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 43 | 0.040 |
Why?
|
| Nutritional Status | 1 | 1998 | 337 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 182 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 1544 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 403 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2022 | 2803 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 208 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 1052 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 12926 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1890 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 778 | 0.030 |
Why?
|
| Pediatrics | 1 | 2021 | 1141 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 14889 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 602 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Contrast Media | 1 | 2017 | 1472 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8223 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 1664 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 144 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2014 | 1335 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 5377 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 4320 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2010 | 319 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 1351 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 6311 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 3343 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 4549 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 2403 | 0.010 |
Why?
|
| Adult | 2 | 2022 | 77950 | 0.010 |
Why?
|
| Drug Overdose | 1 | 2004 | 81 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17523 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 12873 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 21445 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 7702 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 37905 | 0.010 |
Why?
|